Cardiol Therapeutics Files 6-K Report
Ticker: CRDL · Form: 6-K · Filed: Apr 14, 2026
Sentiment: neutral
Topics: 6-K, foreign-issuer, regulatory-filing
TL;DR
Cardiol Therapeutics filed a 6-K on 4/14/26. Standard report, no major news.
AI Summary
Cardiol Therapeutics Inc. filed a Form 6-K on April 14, 2026, reporting information as a foreign issuer. The filing includes standard documents like the 6-K form itself and Exhibit 99.1, along with a graphic file. The company's mailing and business addresses are both listed as 602-2265 Upper Middle Road East, Oakville, A6, L6H 0G5.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Cardiol Therapeutics' status as a foreign issuer.
Risk Assessment
Risk Level: low — This filing is a routine report for a foreign issuer and does not contain specific financial or operational news that would indicate a change in risk.
Key Players & Entities
- Cardiol Therapeutics Inc. (company) — Filer
- 0001702123 (company) — CIK
- 2026-04-14 (date) — Filing Date
- 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 (address) — Mailing and Business Address
FAQ
What type of filing is this?
This is a Form 6-K, a report of a foreign issuer.
When was this filing submitted?
The filing date was April 14, 2026.
What is the CIK number for Cardiol Therapeutics Inc.?
The CIK number is 0001702123.
What are the company's mailing and business addresses?
Both are listed as 602-2265 Upper Middle Road East, Oakville, A6, L6H 0G5.
What are the included documents in this filing?
The filing includes FORM 6-K, EXHIBIT 99.1, and a GRAPHIC file.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 14, 2026 regarding Cardiol Therapeutics Inc. (CRDL).